You are here

Journal > Ophthalmology

Therapeutic Advances in Ophthalmology

eISSN: 25158414 | ISSN: 25158414 | Current volume: 15 | Current issue: 1 Frequency: Yearly
Download flyer Recommend to Library

Journal Highlights

  • Launched in 2018
  • Gold open access journal – all articles are made freely available online immediately upon publication
  • Rigorous peer review
  • Listed in PubMed and indexed in Web of Science and Emerging Sources Citation Index Expanded (ESCI) and SCOPUS

Therapeutic Advances in Ophthalmology (TAOP) is a peer-reviewed open access journal delivering the highest quality articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of ophthalmology. Please see the Aims and Scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).

Diversity, Equity and Inclusion Statement

Therapeutic Advances in Ophthalmology (TAOP) promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the ophthalmology community.

Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.

We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.

We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.

Submission information

Submit your manuscript at today at https://mc.manuscriptcentral.com/taop

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.


Open access article processing charge (APC) information

Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that all articles are freely accessible online in perpetuity under a Creative Commons licence.

The APC for this journal is currently 2650 USD. The article processing charge for Plain Language Summary is 4500 USD.

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.


Contact

Please direct any queries to TAOphthalmology@sagepub.co.uk  

Therapeutic Advances in Ophthalmology delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of eye diseases. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in ophthalmology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.

The editors welcome original research articles across all areas of ophthalmology.
 
The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.
 
Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. The trial registry name and URL, and registration number must be included at the end of the abstract.
 
The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees.

 

Editor-in-Chief
Joshua Cameron PhD FAAO Western University of Health Sciences College of Optometry in Pomona, CA, USA
Managing Editor
Sarangi Thattyot Kariyath SAGE Publications
Assistant Managing Editor
Shobhna Devrani SAGE Publishing, India
Associate Editors
Enrico Borrelli MD University Vita Salute, IRCCS Ospedale San Raffaele, Milan, Italy
Raymond P Najjar PhD Singapore Eye Research Institute, Singapore
Rohan Bir Singh MD Harvard Medical School, Boston, MA, USA and Leiden University Medical Center, The Netherlands
Editorial Board Member
Chi-Chao Chan MD National Eye Institute, National Institutes of Health, Bethesda, MD, USA
Nigel G. F. Cooper PhD University of Louisville, KY, USA
Richard D. Dix PhD Emory University School of Medicine, Georgia State University, Atlanta, GA, USA
Zisis Gatzioufas MD, PhD, FMH, FEBO University Hospital Basel, Switzerland
Pearse Keane MD MSc FRCOphth MRCSI Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK
Stuart A. Lipton PhD MD Scripps Research Institute, and University of California at San Diego, La Jolla, CA, USA
Daniel E. Maidana MD University of Illinois at Chicago, Chicago, IL, USA
Mariya Moosajee MBBS PhD FRCOphth University College London, London, UK
Monisha Nongpiur MD, PhD Singapore Eye Research Institute, Duke-NUS Medical School, Singapore City, Singapore
Noorjahan Panjwani PhD Tufts University School of Medicine, Boston, MA, USA
Giuseppe Querques MD PhD University Vita-Salute San Raffaele Scientific Institute, Milan, Italy
Vito Romano MD, PGDip CRS, MHA University of Liverpool, UK
Ronald H. Silverman PhD Columbia University Medical Center, NY, USA
Nir Sorkin MD Tel Aviv Medical Center, Tel Aviv, Israel
Liza Sharmini Ahmad Tajudin, MD, PhD Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia
Yuankai K. Tao, PhD Vanderbilt University, Nashville, TN, USA
Irena Tsui MD Stein Eye Institute and Doheny Eye Institute, UCLA, Los Angeles, CA, USA
Javier Zarranz-Ventura MD, PhD, FEBO Institut Clínic de Oftalmología (ICOF), Hospital Clínic de Barcelona and Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Spain
Kang Zhang MD PhD Sichuan University, Chengdu, China
  • Clarivate Analytics: Emerging Sources Citation Index (ESCI)
  • Directory of Open Access Journals (DOAJ)
  • EBSCO
  • ProQuest
  • PubMed Central (PMC)
  • Scopus

Manuscript submission guidelines can be accessed on Sage Journals.